Scott Randal W. sold BBIO
May 15, 2026 · Form 4 insider transaction
Scott Randal W. sold 200 shares of BridgeBio Pharma, Inc. at $69.12 per share, a transaction worth $13.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$69.12
Total value
$13.8K
InsiderScott Randal W.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after11,589
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.